logo
Select company
Select metric
43.39%Cash to Assets Ratio
VS
Market
89
Sector
68
Industry
57
History
26
$ 58Close
$ 5.56 - $ 63.65 52-Week Range
Ticker Information

Ticker

QURE

Company Name

UNIQURE NV

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

UNIQURE NV - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

QURE - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 584.89M$ 253.78M43.39%
3/31/2025$ 605.4M$ 217.23M35.88%
12/31/2024$ 556.54M$ 158.93M28.56%
9/30/2024$ 645.81M$ 251.63M38.96%
6/30/2024$ 730.85M$ 287.88M39.39%
3/31/2024$ 770.05M$ 243.06M31.56%
12/31/2023$ 831.69M$ 241.36M29.02%
9/30/2023$ 871.55M$ 229.48M26.33%
6/30/2023$ 942.77M$ 513.6M54.48%
3/31/2023$ 631M$ 153.85M24.38%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • UNIQURE NV's latest trailing twelve months (TTM) Cash to Assets stands at 79.74%.
  • Over the past 5 years, UNIQURE NV's average Cash to Assets has been 52.36%.
  • The median Cash to Assets for UNIQURE NV during this period was 48.93%
  • UNIQURE NV reached its highest Cash to Assets over the past 5 years at 86.37%.
  • The lowest Cash to Assets recorded by UNIQURE NV in the same timeframe 24.38%

UNIQURE NV's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
NUVB : NUVATION BIO INC 38.31%ZBIO : ZENAS BIOPHARMA INC 15.01%ABUS : ARBUTUS BIOPHARMA CORP 36.23%IMNM : IMMUNOME INC 48.63%VIR : VIR BIOTECHNOLOGY INC 25.1%TSHA : TAYSHA GENE THERAPIES INC 94.61%CAPR : CAPRICOR THERAPEUTICS INC 17.4%RLAY : RELAY THERAPEUTICS INC 15.94%BCYC : BICYCLE THERAPEUTICS PLC 86.69%TNGX : TANGO THERAPEUTICS INC 16.69%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for UNIQURE NV is calculated as follows: CashnEq [ $ 279.49M ] / Assets [ $ 350.51M ]
(=) Cash to Assets [ 79.74% ]

QURE - Cash to Assets Ratio, Last 5 years

24.38%

Minimum

Mar 31, 2023

86.37%

Maximum

Jun 30, 2021

52.36%

Average

48.93%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.84% with a standard deviation of 9.62%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.95K
min0%
max40.92%
average9.84%
median6.44%
std9.62%